XML 25 R14.htm IDEA: XBRL DOCUMENT v3.21.1
LOANS RECEIVABLE AND OTHER INVESTMENTS
 3 Months Ended
Mar. 31, 2021
Receivables [Abstract]  
LOANS RECEIVABLE AND OTHER INVESTMENTS LOANS RECEIVABLE AND OTHER INVESTMENTS
As of March 31, 2021 and December 31, 2020, the Company’s loans receivable and other investments consisted of the following (dollars in thousands):
March 31, 2021
InvestmentQuantity
as of
March 31,
2021		Property Type
Principal Balance
as of
March 31,
2021 (1)
Book Value
as of
March 31,
2021		Book Value
as of
December 31, 2020		Weighted Average Contractual Interest Rate / Rate of ReturnWeighted Average Annualized Effective Interest Rate / Rate of ReturnMaturity Date
as of
March 31,
2021
Loans Receivable:
Mortgage1 Specialty Hospital$19,000 $19,000 $19,000 10.0 %10.0 %01/31/27
Construction1 Senior Housing3,343 3,350 3,352 8.0 %7.8 %09/30/22
Other16 Multiple42,349 38,372 39,005 6.8 %6.9 %12/03/21- 08/31/28
18 64,692 60,722 61,357 7.8 %7.9 %
Allowance for loan losses— (4,358)(2,458)
$64,692 $56,364 $58,899 
Other Investments:
Preferred Equity6 Skilled Nursing / Senior Housing44,634 44,861 43,940 11.3 %11.3 %N/A
Total 24 $109,326 $101,225 $102,839 9.2 %9.3 %
(1)    Principal balance includes amounts funded and accrued but unpaid interest / preferred return and excludes capitalizable fees.
As of March 31, 2021 and December 31, 2020, the Company had four loans receivable investments, with an aggregate principal balance of $2.0 million and $2.1 million, respectively, that were considered to have deteriorated credit quality. As of March 31, 2021 and December 31, 2020, the book value of the outstanding loans with deteriorated credit quality was $0.4 million and $0.5 million, respectively.
During the three months ended March 31, 2021 and 2020, the Company increased its allowance for loan losses by $1.9 million and $0.7 million, respectively.
As of March 31, 2021, the Company had a $4.4 million allowance for loan losses and three loans receivable investments with no book value were on nonaccrual status. As of March 31, 2021, the Company did not consider any preferred equity investments to be impaired, and no preferred equity investments were on nonaccrual status.
As of December 31, 2020, the Company had a $2.5 million allowance for loan losses and two loans receivable investments with no book value were on nonaccrual status. As of December 31, 2020, the Company did not consider any preferred equity investments to be impaired, and no preferred equity investments were on nonaccrual status.